dehydroabietylamine has been researched along with Kahler Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Alharbi, SA; Jung, YY; Nasif, O; Sethi, G; Um, JY | 1 |
1 other study(ies) available for dehydroabietylamine and Kahler Disease
| Article | Year |
|---|---|
Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Gene Expression Regulation; Humans; Janus Kinase 1; Janus Kinase 2; Multiple Myeloma; Phosphorylation; Signal Transduction; STAT3 Transcription Factor | 2021 |